Dr George Medvedev
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context (NCT06428838) | Dr George Medvedev | 2024-09-30 |
| Impact of Photobiomodulation on Objective, Physiological Measures of Brain Function in Individuals With Post-Concussion Syndrome (NCT05097222) | Dr George Medvedev | 2022-01-27 |
Track Dr George Medvedev automatically
Every clearance here is in the API, with alerts when new ones post.